Ginkgo biloba is one of the oldest living tree species and one of the most extensively studied botanicals for cognitive and circulatory support, with standardized leaf extract (typically EGb 761) linked in clinical trials to modest improvements in blood flow and, in some populations, cognitive symptoms, though results across the full body of research are mixed. This guide covers the mechanisms, evidence, dosing, and safety in depth.
Quick Facts
- Category: Botanical extract (from Ginkgo biloba tree leaves)
- Key constituents: Flavone glycosides, terpene lactones (ginkgolides, bilobalide)
- Most-studied form: Standardized extract EGb 761 (24% flavone glycosides, 6% terpene lactones)
- Key benefits: Peripheral circulation, cognitive symptom support in specific populations
- Evidence status: Mixed; benefits appear most consistent in people with existing circulatory or cognitive impairment
What Is Ginkgo Biloba?
Ginkgo biloba is a tree species with no close living relatives, often called a \"living fossil\" because its lineage dates back over 200 million years. Ginkgo leaf extract has been used in Traditional Chinese Medicine for centuries and became one of the most-studied herbal extracts in modern Western clinical research beginning in the mid-20th century, particularly in Germany and France. Most rigorous clinical research uses a specific standardized extract, commonly referred to as EGb 761, standardized to 24% flavone glycosides and 6% terpene lactones, rather than raw ginkgo leaf, which has much more variable and generally lower concentrations of active compounds.
Mechanisms of Action
Ginkgo's terpene lactones, particularly the ginkgolides, are potent inhibitors of platelet-activating factor, a compound involved in blood clotting and inflammation, which is the primary mechanism behind ginkgo's studied effects on peripheral blood flow, though this same mechanism is responsible for its bleeding-risk interactions discussed below. Ginkgo flavonoids provide antioxidant activity, scavenging free radicals in vascular and neural tissue. Ginkgo extract has also been shown in laboratory and some human studies to improve blood flow through vasodilation and reduced blood viscosity, which underlies its studied use for peripheral arterial disease (intermittent claudication) and some circulatory symptoms. In the brain specifically, ginkgo's combined antioxidant and circulatory effects are proposed to support neuronal function, particularly under conditions of reduced blood flow or existing cognitive impairment, though the specific relevance to healthy, non-impaired cognition is less well supported.
Evidence-Based Benefits
Peripheral arterial disease and circulatory symptoms. Evidence level: Established. Multiple randomized controlled trials and meta-analyses show standardized ginkgo extract (EGb 761) modestly improves pain-free walking distance in people with peripheral arterial disease (intermittent claudication), an effect considered one of ginkgo's most consistently replicated clinical benefits.
Cognitive symptoms in dementia and mild cognitive impairment. Evidence level: Mixed. Some randomized trials and meta-analyses report modest improvements in cognitive symptoms and daily functioning in people with mild-to-moderate dementia or mild cognitive impairment when taking standardized ginkgo extract for 12-24 weeks or longer, though other large trials, including studies in cognitively healthy older adults aimed at dementia prevention, have not found a significant benefit, leading major reviews to describe the overall evidence as inconsistent.
Cognitive performance in healthy adults. Evidence level: Weak/inconsistent. Trials in cognitively healthy young and middle-aged adults generally show minimal to no meaningful benefit of ginkgo on memory or cognitive performance, suggesting any cognitive benefit is more relevant to populations with existing impairment or reduced cerebral blood flow rather than to enhancing already-normal cognitive function.
Tinnitus. Evidence level: Mixed. Some smaller trials suggest ginkgo may modestly reduce tinnitus severity, though larger and more rigorous trials have generally found no significant benefit over placebo, and current evidence does not strongly support ginkgo as an effective tinnitus treatment.
Dosage & Timing
Clinical trials most commonly use 120-240mg daily of standardized EGb 761 extract, divided into two doses, continued for at least 12-24 weeks before assessing cognitive or circulatory outcomes, since benefits (where present) generally build gradually rather than appearing acutely. There is no official Recommended Dietary Allowance for ginkgo.
Interactions & Contraindications
This is one of ginkgo's most important safety considerations: because ginkgolides inhibit platelet-activating factor, ginkgo has a well-documented antiplatelet effect and can meaningfully increase bleeding risk when combined with anticoagulant or antiplatelet medications, including warfarin, aspirin, clopidogrel, and other blood thinners; this combination should only be undertaken with direct medical supervision. Ginkgo should generally be discontinued at least 1-2 weeks before scheduled surgery, given its effect on bleeding risk. Ginkgo may also interact with certain anti-seizure medications, potentially lowering the seizure threshold in susceptible individuals, and there are some documented interactions with antidepressant medications, particularly SSRIs and MAOIs, related to bleeding risk and rare serotonergic effects.
Safety, Side Effects & Warnings
Standardized ginkgo extract has a generally favorable safety profile in clinical trials at studied doses, with the most common side effects being mild headache, dizziness, gastrointestinal upset, and allergic skin reactions in sensitive individuals. The most clinically significant safety concern is increased bleeding risk, particularly at higher doses, when combined with blood-thinning medications, or around the time of surgery. Raw or unprocessed ginkgo seeds (distinct from standardized leaf extract) contain a compound called ginkgotoxin and can be toxic, particularly to children, if consumed in quantity; commercial leaf extract supplements do not carry this specific risk since they are made from the leaf rather than the seed.
ⓘ Anyone taking blood thinners, anti-seizure medications, or scheduled for surgery should discuss ginkgo use with their healthcare provider well in advance, given its well-documented effect on bleeding risk.
Frequently Asked Questions
Does ginkgo biloba actually improve memory?
Evidence is mixed. Some trials in people with existing cognitive impairment or dementia show modest benefits with long-term (12-24 week or longer) standardized extract use, but studies in cognitively healthy adults generally show little to no meaningful memory benefit, suggesting ginkgo's cognitive effects, where present, are more relevant to impaired than healthy cognition.
Is ginkgo biloba a blood thinner?
Yes, ginkgo has documented antiplatelet activity through inhibition of platelet-activating factor, and this is its most clinically significant safety consideration, particularly for people on anticoagulant or antiplatelet medications or those scheduled for surgery.
What is ginkgo biloba's strongest evidence-based use?
Its most consistently replicated clinical benefit is modestly improving pain-free walking distance in people with peripheral arterial disease (intermittent claudication), a circulatory condition, which has a more robust evidence base than its cognitive uses.
Who should avoid ginkgo biloba?
Anyone on anticoagulant or antiplatelet medications, those with seizure disorders or on anti-seizure medication, and anyone scheduled for surgery within a couple of weeks should consult a healthcare provider before using ginkgo, given its effect on bleeding risk and potential seizure threshold.
Scientific References
- Birks, J., Grimley Evans, J. "Ginkgo Biloba for Cognitive Impairment and Dementia." Cochrane Database of Systematic Reviews, 2009;1:CD003120.
- DeKosky, S. T., Williamson, J. D., Fitzpatrick, A. L., et al. "Ginkgo Biloba for Prevention of Dementia: A Randomized Controlled Trial." JAMA, 2008;300(19):2253-2262.
- Nicolai, S. P., Kruidenier, L. M., Bendermacher, B. L., Prins, M. H., Teijink, J. A. "Ginkgo Biloba for Intermittent Claudication." Cochrane Database of Systematic Reviews, 2013;6:CD006888.
- Bent, S., Goldberg, H., Padula, A., Avins, A. L. "Spontaneous Bleeding Associated With Ginkgo Biloba: A Case Report and Systematic Review of the Literature." Journal of General Internal Medicine, 2005;20(7):657-661.
Disclaimer
This article is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It does not constitute medical advice and is independent of any specific product or brand. Always consult a qualified healthcare provider before beginning any new supplement regimen, particularly if you take blood-thinning or anti-seizure medication or are scheduled for surgery.
